Target Name: CYSTM1
NCBI ID: G84418
Review Report on CYSTM1 Target / Biomarker Content of Review Report on CYSTM1 Target / Biomarker
CYSTM1
Other Name(s): CYTM1_HUMAN | putative nuclear protein ORF1-FL49 | Putative nuclear protein ORF1-FL49 | ORF1-FL49 | Cysteine rich transmembrane module containing 1 | cysteine rich transmembrane module containing 1 | UPF0467 protein C5orf32 | C5orf32 | Cysteine-rich and transmembrane domain-containing protein 1

CYSTM1: A Non-Coding RNA Molecule with Potential as A Drug Target

CYSTM1 (CYTM1_HUMAN), also known as CSF-1, is a non-coding RNA molecule that plays a crucial role in the development and maintenance of tissues. It is a key regulator of cell proliferation and has been implicated in a wide range of biological processes, including cell signaling, cell adhesion, and tissue repair.

One of the most promising aspects of CYSTM1 is its potential as a drug target. Its involvement in various signaling pathways has led to the development of new treatments for a range of diseases. CYSTM1 has also been identified as a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a drug target, CYSTM1 has also been extensively studied for its role in various biological processes. Its functions have been described in various research articles, including the regulation of cell cycle progression, the control of cell adhesion, and the regulation of tissue repair.

One of the most well-studied functions of CYSTM1 is its role in cell cycle progression. CYSTM1 is a key regulator of the G1/S transition, which is a critical step in the cell cycle that leads to the completion of DNA replication and the start of the S phase. The G1/S transition is critical for cell growth and development, and it is during this stage that CYSTM1 helps to ensure that the cell has enough copies of its genetic material to support future growth and division.

In addition to its role in cell cycle progression, CYSTM1 has also been shown to play a key role in cell adhesion. CYSTM1 is a critical regulator of cell adhesion, which is the process by which cells stick together to form tissues and organs. It is during this stage that CYSTM1 helps to ensure that cells stick together and maintain their proper spatial order, which is essential for the development and maintenance of tissues.

Another function of CYSTM1 is its role in tissue repair. CYSTM1 is a critical regulator of the DNA damage response, which is the process by which the cell responds to DNA damage. When DNA damage occurs, CYSTM1 helps to ensure that the cell is able to repair the damage and prevent the damage from having a negative impact on the cell's genetic material. This is essential for the development and maintenance of tissues, and it is during this stage that CYSTM1 plays a key role in repairing damaged tissue.

In conclusion, CYSTM1 is a non-coding RNA molecule that plays a crucial role in the development and maintenance of tissues. Its involvement in various signaling pathways and its functions as a potential drug target and biomarker make it an attractive target for further research. Further studies are needed to fully understand the role of CYSTM1 in various biological processes and to develop new treatments based on its potential as a drug target.

Protein Name: Cysteine Rich Transmembrane Module Containing 1

The "CYSTM1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYSTM1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CYTB | CYTH1 | CYTH2 | CYTH3 | CYTH4 | CYTIP | CYTL1 | Cytochrome b5 reductase | Cytochrome bc1 complex | Cytochrome c oxidase | Cytochrome P450 1A (CYP1A) | Cytochrome P450 26 | Cytochrome P450 3A (CYP3A) | Cytochrome P450 4A | Cytochrome P450 Enzymes | Cytohesin | Cytoplasmatic dynein | Cytoplasmic dynein complex | CYTOR | CYYR1 | CYYR1-AS1 | CZIB | D21S2088E | D2HGDH | DAAM1 | DAAM2 | DAAM2-AS1 | DAB1 | DAB1-AS1 | DAB2 | DAB2IP | DACH1 | DACH2 | DACT1 | DACT2 | DACT3 | DACT3-AS1 | DAD1 | DAG1 | DAGLA | DAGLB | DALRD3 | DANCR | DAND5 | DANT2 | DAO | DAOA | DAOA-AS1 | DAP | DAP3 | DAPK1 | DAPK1-IT1 | DAPK2 | DAPK3 | DAPL1 | DAPP1 | DARS1 | DARS1-AS1 | DARS2 | DAW1 | DAXX | DAZ1 | DAZ2 | DAZ3 | DAZ4 | DAZAP1 | DAZAP2 | DAZAP2P1 | DAZL | DBET | DBF4 | DBF4B | DBF4P1 | DBH | DBH-AS1 | DBI | DBIL5P | DBIL5P2 | DBIP2 | DBIRD complex | DBN1 | DBNDD1 | DBNDD2 | DBNL | DBP | DBR1 | DBT | DBX1 | DBX2 | DCAF1 | DCAF10 | DCAF11 | DCAF12 | DCAF12L1 | DCAF12L2 | DCAF13 | DCAF13P3 | DCAF15 | DCAF16 | DCAF17